Skip to main content

Table 1 The clinical characteristic information of the HCC patients in TCGA and ICGC

From: DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination

Characteristics

TCGA (%)

ICGC (%)

Age

 < 60

177 (47.32)

50 (27.59)

 ≥ 60

196 (52.41)

210 (72.41)

NA

1 (0.27)

 

Gender

 Male

253 (67.65)

192 (73.71)

 Female

121 (32.35)

68 (26.29)

Survival status

 Alive

238 (63.64)

214 (81.47)

 Dead

130 (34.76)

46 (18.53)

 NA

6 (1.60)

 

Stage

 I

173 (46.26)

40 (15.52)

 II

87 (23.26)

117 (45.69)

 III

85 (22.73)

80 (30.60)

 IV

5 (1.34)

23 (8.19)

 NA

24 (6.42)

 

Histological grade

 G1

55 (14.71)

NA

 G2

178 (47.59)

NA

 G3

124 (33.16)

NA

 G4

12 (3.21)

NA

 NA

5 (1.34)

 

T classification

 T1

183 (48.93)

NA

 T2

95 (25.40)

NA

 T3

80 (21.39)

NA

 T4

13 (3.48)

NA

 NA

3 (0.80)

 

N classification

 N0

254 (67.91)

NA

 N1

4 (1.07)

NA

 NX

115 (30.75)

NA

 NA

1 (0.27)

 

M classification

 M0

268 (71.66)

NA

 M1

4 (1.07)

NA

 MX

102 (27.27)

 
  1. NA not available